Residency · Residency · Pediatrics
Necrotizing Enterocolitis
Overview
Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in neonates, primarily affecting preterm infants. It occurs in 5-12% of very low birth weight infants (under 1500 grams) and carries a mortality rate of 20-30% overall, rising to 50% in cases requiring surgery. NEC is characterized by intestinal inflammation, ischemia, and necrosis, with a multifactorial pathogenesis involving mucosal immaturity, abnormal bacterial colonization, and feeding practices.
Pathophysiology
The preterm intestine has an immature barrier with increased permeability that permits bacterial translocation. The neonatal microbiome in NEC is dysbiotic, showing reduced diversity with predominance of Proteobacteria (particularly Enterobacteriaceae). The immature mucosal immune response features exaggerated TLR4 (Toll-like receptor 4) signaling, which drives a destructive cascade: intestinal epithelial apoptosis, impaired mucosal repair through reduced Wnt/beta-catenin signaling, and mesenteric vasoconstriction leading to ischemia. Formula feeding alters the microbiome unfavorably compared to human milk. The final common pathway involves bacterial translocation across the compromised barrier, release of inflammatory cytokines (TNF-alpha, IL-1, IL-8), and coagulation necrosis of the bowel wall.
Risk Factors
Prematurity is the strongest risk factor for NEC. Additional factors include formula feeding, intestinal ischemia or hypoxia, abnormal bacterial colonization (promoted by antibiotic exposure and prolonged NICU stay), packed red blood cell transfusions (transfusion-associated NEC), hemodynamically significant patent ductus arteriosus, polycythemia, and congenital heart disease (especially ductal-dependent lesions). Maternal factors contributing to risk include chorioamnionitis, preeclampsia, and cocaine use.
Clinical Presentation
NEC typically presents at 2-6 weeks of life in preterm infants but earlier in term infants. Early signs are often subtle: feeding intolerance with increased gastric residuals or emesis, abdominal distension, and occult or gross bloody stools. As the disease progresses, bilious emesis or aspirates develop, the abdominal wall becomes erythematous or discolored, and bowel sounds become absent. Systemic signs include temperature instability, lethargy, apnea, bradycardia, hypotension, metabolic acidosis, thrombocytopenia, and disseminated intravascular coagulation.
Bell Staging Criteria
Stage I (Suspected NEC)
Stage I presents with non-specific systemic signs including temperature instability, apnea, and lethargy. Intestinal signs include mild abdominal distension and feeding intolerance. Stools may test positive for occult blood. Abdominal radiographs are normal or show only mild ileus.
Stage II (Definite NEC)
Stage II adds definite intestinal findings to the Stage I picture: absent bowel sounds, abdominal tenderness, and grossly bloody stools. The radiographic hallmark is pneumatosis intestinalis (intramural gas), which is pathognomonic for NEC. Portal venous gas may also be seen. Stage IIA describes a mildly ill infant, while Stage IIB indicates moderate illness with metabolic acidosis and thrombocytopenia.
Stage III (Advanced NEC)
Stage III represents severe, advanced disease with clinical deterioration, peritonitis, abdominal wall erythema or induration, hypotension, DIC, and multiorgan failure. Radiographically, pneumoperitoneum (free air) indicates bowel perforation (Stage IIIB), while Stage IIIA describes intact bowel with ascites.
| Stage | Systemic Signs | Intestinal Signs | Radiographic Findings | Treatment |
|---|---|---|---|---|
| IA | Temperature instability, apnea, lethargy | Mild distension, feeding intolerance, occult blood in stool | Normal or mild ileus | NPO, antibiotics x 3 days |
| IB | Same as IA | Same as IA | Normal or mild ileus | NPO, antibiotics x 3 days |
| IIA | Same as Stage I | Absent bowel sounds, abdominal tenderness, grossly bloody stools | Pneumatosis intestinalis | NPO, antibiotics x 7-14 days |
| IIB | Mild acidosis, thrombocytopenia | Abdominal wall edema, palpable mass | Pneumatosis, portal venous gas | NPO, antibiotics x 14 days |
| IIIA | Hypotension, DIC, acidosis | Peritonitis, marked distension, erythema | Ascites, fixed loop | Medical + surgical consult |
| IIIB | Shock, multiorgan failure | Perforation signs | Pneumoperitoneum | Surgical intervention |
Radiographic Findings
Serial abdominal radiographs obtained every 6-8 hours during the acute phase are essential for monitoring. Dilated bowel loops are an early but nonspecific finding. Pneumatosis intestinalis -- intramural gas appearing as linear or bubbly lucencies in the bowel wall -- is the hallmark finding. Portal venous gas tracking through the portal system represents a grave sign. Pneumoperitoneum indicates perforation and is best visualized on left lateral decubitus or cross-table lateral films. A fixed dilated loop unchanged on serial films suggests a necrotic, non-viable bowel segment.
Laboratory Findings
Laboratory studies reveal leukocytosis or leukopenia with a left shift and thrombocytopenia on CBC. Metabolic acidosis with lactic acid elevation is characteristic. Hyponatremia develops as third-spacing occurs. CRP is elevated. Blood cultures are positive in approximately 30% of cases. DIC panel shows elevated PT/aPTT, decreased fibrinogen, and elevated D-dimer.
Medical Management (Bell Stage I-II)
Medical management centers on bowel rest with nothing by mouth for 7-14 days depending on severity. Gastric decompression with a Replogle or orogastric tube on continuous suction relieves distension. Broad-spectrum antibiotics are initiated, typically ampicillin plus gentamicin plus metronidazole (or piperacillin-tazobactam), continued for 7-14 days based on stage. Intravenous fluids and total parenteral nutrition maintain hydration and nutrition during bowel rest. Cardiovascular support with volume resuscitation and vasopressors is provided as needed. Serial monitoring includes abdominal examinations, laboratory studies (CBC, CRP, blood gas), and radiographs every 6-8 hours. Blood product support includes platelet transfusion and fresh frozen plasma for DIC.
Surgical Management
The absolute surgical indication is pneumoperitoneum, indicating intestinal perforation. Relative indications include clinical deterioration despite maximal medical therapy, a fixed loop on serial radiographs, portal venous gas, abdominal wall cellulitis, and a palpable abdominal mass. Surgical options include laparotomy with resection of necrotic bowel and creation of an enterostomy, or primary peritoneal drainage as a temporizing or definitive measure in extremely low birth weight infants too unstable for laparotomy. The NET trial demonstrated no significant difference in outcomes between peritoneal drainage and laparotomy in ELBW infants.
Prevention Strategies
Human Milk
Exclusive human milk feeding reduces NEC risk by 50-80% and represents the single most important preventive strategy. Donor human milk should be used when maternal milk is unavailable. Proposed protective mechanisms include secretory IgA, lactoferrin, human milk oligosaccharides (HMOs), and growth factors that promote mucosal integrity.
Probiotics
Meta-analyses demonstrate that probiotics reduce NEC stage II and above as well as mortality. Commonly studied strains include Lactobacillus, Bifidobacterium, and Saccharomyces boulardii. However, controversy persists: there is no FDA-regulated probiotic product for neonates, contamination concerns exist, and the optimal strain and dose remain unknown. Some NICUs have adopted routine prophylaxis while others await larger safety trials.
Other Strategies
Standardized feeding protocols with slow advancement of feeds reduce NEC risk. Prolonged empiric antibiotics should be avoided as they promote dysbiosis. Caution with packed red blood cell transfusions is advised, though withholding feeds during transfusion remains controversial. Antenatal steroids reduce NEC incidence through enhanced intestinal maturation.
Complications and Outcomes
Major complications of NEC include short bowel syndrome following extensive resection, intestinal stricture as a late complication (occurring in 10-35% of cases), cholestasis from prolonged TPN use, neurodevelopmental impairment, and recurrence in approximately 5% of survivors.
<image>An abdominal radiograph illustration of a neonate with NEC showing pneumatosis intestinalis (intramural gas appearing as bubbly or linear lucencies in the bowel wall), portal venous gas (branching linear lucencies over the liver), and dilated bowel loops. Labeled with arrows pointing to each finding. Medical radiology teaching style.</image>
<image>A cross-sectional illustration of the intestinal wall in NEC, comparing normal neonatal intestinal mucosa with intact epithelial barrier on the left to NEC-affected bowel on the right showing mucosal necrosis, bacterial translocation through disrupted tight junctions, inflammatory cell infiltration, intramural gas bubbles (pneumatosis), and mesenteric vascular thrombosis. Medical histopathology illustration style.</image>
<image>A clinical staging diagram of NEC using the modified Bell criteria, presented as a table with three stages (I, II, III) showing systemic signs, intestinal signs, and radiographic findings for each stage, with corresponding treatment approach listed below each stage. Color-coded from yellow (suspected) to red (advanced).</image>
Clinical Pearls
Pneumatosis intestinalis is pathognomonic for NEC, but its absence does not rule out the diagnosis. A "normal" abdominal radiograph in a preterm infant with clinical signs does not exclude early NEC, and serial imaging is essential. Thrombocytopenia is often the first laboratory abnormality and may herald clinical deterioration before obvious radiographic changes appear. Human milk is the single most important preventive strategy against NEC. Feeding intolerance alone is nonspecific, but the combination of abdominal distension, bloody stools, and systemic signs should prompt immediate evaluation for NEC. After recovery, surveillance for intestinal stricture is important, and a contrast enema should be performed before restarting full feeds. Surgical NEC carries worse neurodevelopmental outcomes than medically managed NEC, underscoring the importance of prevention and early intervention.
References
- Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255-264.
- Bell MJ, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7.
- Patel RM, et al. Causes and timing of death in extremely premature infants. J Perinatol. 2015;35(12):961-966.
- AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;(4):CD005496.
- Moss RL, et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation (NET trial). N Engl J Med. 2006;354(21):2225-2234.
